Profile
Sector:
HealthcareIndustry:
Medical Care FacilitiesCountry:
United StatesIPO:
23 June 2022Website:
http://www.ehab.comNext earnings report:
06 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 28 Oct 2024 22:18:15 GMTDividend
Analysts recommendations
Institutional Ownership
EHAB Latest News
On September 30, 2024, Vanguard Group Inc, a prominent investment firm, executed a significant transaction involving the shares of Enhabit Inc (EHAB, Financial). The firm reduced its holdings by 626,911 shares, which adjusted its total stake in the company to 2,976,480 shares.
Enhabit, Inc. (NYSE:EHAB ) Q2 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President & CEO Crissy Carlisle - CFO Conference Call Participants Noah Erni - Jefferies Ben Rossi - Citi A.J. Rice - UBS Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's second quarter 2024 earnings conference call.
Enhabit (EHAB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago.
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Enhabit (EHAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enhabit (EHAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. In connection with the fil.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”) today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the “SEC”) in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital M.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. Enhabit's President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Tuesday, June 11, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Ho.
Enhabit, Inc. (NYSE:EHAB ) Q3 2023 Results Conference Call November 8, 2023 10:00 AM ET Company Participants Jordan Loyd - Mergers & Acquisitions Director, Corporate Development Barb Jacobsmeyer - President and Chief Executive Officer Crissy Carlisle - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Whit Mayo - Leerink Partners Jamie Perse - Goldman Sachs Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's Third Quarter 2023 Earnings Conference Call. At this time, I'd like to inform all participants that their lines will be in a listen-only mode.
What type of business is Enhabit?
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
What sector is Enhabit in?
Enhabit is in the Healthcare sector
What industry is Enhabit in?
Enhabit is in the Medical Care Facilities industry
What country is Enhabit from?
Enhabit is headquartered in United States
When did Enhabit go public?
Enhabit initial public offering (IPO) was on 23 June 2022
What is Enhabit website?
https://www.ehab.com
Is Enhabit in the S&P 500?
No, Enhabit is not included in the S&P 500 index
Is Enhabit in the NASDAQ 100?
No, Enhabit is not included in the NASDAQ 100 index
Is Enhabit in the Dow Jones?
No, Enhabit is not included in the Dow Jones index
When was Enhabit the previous earnings report?
No data
When does Enhabit earnings report?
The next expected earnings date for Enhabit is 06 November 2024